rs2502815
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005122.5(NR1I3):c.239-99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 1,273,808 control chromosomes in the GnomAD database, including 47,121 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6300 hom., cov: 32)
Exomes 𝑓: 0.26 ( 40821 hom. )
Consequence
NR1I3
NM_005122.5 intron
NM_005122.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.635
Publications
25 publications found
Genes affected
NR1I3 (HGNC:7969): (nuclear receptor subfamily 1 group I member 3) This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
NR1I3 Gene-Disease associations (from GenCC):
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.412 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.283 AC: 42926AN: 151912Hom.: 6292 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42926
AN:
151912
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.265 AC: 297223AN: 1121778Hom.: 40821 AF XY: 0.264 AC XY: 148037AN XY: 561730 show subpopulations
GnomAD4 exome
AF:
AC:
297223
AN:
1121778
Hom.:
AF XY:
AC XY:
148037
AN XY:
561730
show subpopulations
African (AFR)
AF:
AC:
8836
AN:
26732
American (AMR)
AF:
AC:
14067
AN:
36996
Ashkenazi Jewish (ASJ)
AF:
AC:
5302
AN:
20912
East Asian (EAS)
AF:
AC:
16250
AN:
37422
South Asian (SAS)
AF:
AC:
19672
AN:
71706
European-Finnish (FIN)
AF:
AC:
10750
AN:
37388
Middle Eastern (MID)
AF:
AC:
920
AN:
3360
European-Non Finnish (NFE)
AF:
AC:
207740
AN:
838636
Other (OTH)
AF:
AC:
13686
AN:
48626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
10466
20931
31397
41862
52328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6920
13840
20760
27680
34600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.283 AC: 42969AN: 152030Hom.: 6300 Cov.: 32 AF XY: 0.286 AC XY: 21220AN XY: 74304 show subpopulations
GnomAD4 genome
AF:
AC:
42969
AN:
152030
Hom.:
Cov.:
32
AF XY:
AC XY:
21220
AN XY:
74304
show subpopulations
African (AFR)
AF:
AC:
12935
AN:
41466
American (AMR)
AF:
AC:
4937
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
904
AN:
3472
East Asian (EAS)
AF:
AC:
2205
AN:
5164
South Asian (SAS)
AF:
AC:
1361
AN:
4816
European-Finnish (FIN)
AF:
AC:
3073
AN:
10556
Middle Eastern (MID)
AF:
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16607
AN:
67958
Other (OTH)
AF:
AC:
626
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1529
3058
4588
6117
7646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1221
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.